Week of December 20, 2022 | Vol. 11, Issue 49


In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates

Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health

Contact Information

Xan Smith

Managing Director

Business Development


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory


Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

JP Morgan Healthcare Conference

January 9-12, 2023 - San Francisco, CA

SCOPE Summit for Clinical Ops Executives

February 6-9, 2023 - Orlando, FL

CPHA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Pharma & Biotech

10 transactions totaling $30 billion

Supplies, Equipment & Services

24 transactions totaling $698 million

Healthcare Facilities & Distributors

5 transactions

Healthcare IT & Managed Care

4 transactions totaling $12 million


Pharma & Biotech

37 transactions totaling $600 million

Supplies, Equipment & Services

25 transactions totaling $476 million

Healthcare Facilities & Distributors

7 transaction totaling $15 million

Healthcare IT & Managed Care

20 transactions totaling $54 million


Pharma & Biotech

27 transactions totaling $1,173 million

Supplies, Equipment & Services

3 transactions totaling $89 million

Healthcare Facilities & Distributors

1 transaction

Healthcare IT & Managed Care

1 transaction

A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022


Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel


A Sampling of Industry Headlines

Crown Bioscience inks deal with ERS Genomics for gene editing tech

Fierce Biotech - December 12, 2022

Kindeva Drug Delivery, Meridian Medical Technologies Complete Merger

Contrace Pharma - December 13, 2022

Amgen to Acquire Horizon Therapeutics in $28B Deal

Contract Pharma - December 13, 2022

Syneos, Medable extend siteless trial pact formed in 2021

Fierce Biotech - December 13, 2022

Takeda to Acquire Oral Allosteric TYK2 Inhibitor from Nimbus Therapeutics

Contract Pharma - December 13, 2022

Fujifilm invests in CRO PhenoVista for access to image assay tech

Fierce Biotech - December 14, 2022



The Brazilian Pharma Market

Brazil has the largest pharmaceutical market in LatAm, and recent political changes have raised speculation about what other changes could be in store. We take a look at the country’s pharma market and explore what could be around the corner. Click here.

Managing Drug Shortages

Shortages are not a new occurrence, but a rise following the pandemic and other global events is leaving many patients unable to access the medicines they need. We discuss how to manage disruptions and ensure treatments reach patients. Click here.